Cancer Pain Global Clinical Trials Review, H2, 2017

2017-08-23
Price :
Published : Aug-2017
No. of Pages : 274

Cancer Pain Global Clinical Trials Review, H2, 2017

Summary

GlobalData’s clinical trial report, “Cancer Pain Global Clinical Trials Review, H2, 2017” provides an overview of Cancer Pain clinical trials scenario. This report provides top line data relating to the clinical trials on Cancer Pain. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database – Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope
– The report provides a snapshot of the global clinical trials landscape
– Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
– The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
– The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
– The Report provides enrollment trends for the past five years
– Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy
– Assists in formulating key business strategies with regards to investment
– Helps in identifying prominent locations for conducting clinical trials which saves time and cost
– Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
– Supports understanding of trials count and enrollment trends by country in global therapeutics market
– Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
– Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Filed in: Pharmaceutical
Publisher : GlobalData
More Reports
Title Price Buy Now

Embera NeuroTherapeutics Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Embera NeuroTherapeutics Inc (Embera) is a contract research company that discovers and develops new treatments. The company's product includes EMB-001, a drug combination for the stress response system and specific brain functions that results in craving and improvement associated with these disorders. It offers preclinical studies, clinical research and clinical trial services. Embera provides products and therapeutics for smoking cessation, cocaine dependence and other addictions. The company operates through other health sciences center to support a cocaine dependence development program. It also provides clinical development and research services. The company operates through its offices in Sudbury and Shreveport. Embera is headquartered in Shreveport, Louisiana, the US. ......
$250

EndoGastric Solutions Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary EndoGastric Solutions Inc (EGS), formerly EsophyX, Inc. is a medical equipment company that manufactures and markets gastroenterology and surgical products. The company's products include esophy-x device and serosa-fuse fasteners. Its esophy-x device is used in reconstructing the gastroesophageal valve. EGS' products are also used to perform transoral incisionless fundoplication. The company's serosa-fuse fasteners are deployed using EsophyX devices to facilitate esophagogastric tissue plications. Its products provide solutions for hospital stay, reduced patient discomfort, faster patient recovery and patient satisfaction programs. The company develops natural orifice surgical products and procedures to treat gastrointestinal diseases. EGS is headquartered in Redmond, Washington......
$250

Courtagen Life Sciences Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Courtagen Life Sciences Inc (Courtagen) is a medical device company that provides neurological treatment solutions. The company's products include neuro-development panels, lysosomal disorder panels, syndrome panels, comprehensive epilepsy panels, focus epilepsy panels, metabolism test equipments and mitochondrial panels. It also provides drug development services such as target discovery, validation, clinical development, clinical trials, decentralized test development, pre-clinical and clinical trial protocol and companion diagnostic services. Courtagen's products are used in treatment of mitochondrial disorders, epilepsy and seizure disorders, and neuro-developmental disorders. The company serves patients and physicians. It operates in the US and Bermuda. Courtagen is headqua......
$250

Cyxone AB – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Cyxone AB (Cyxone) is a biopharmaceutical company that develops cyclotide drugs for immune-related diseases. The company's lead product include T20K, a compound to inhibit pro-inflammatory cytokines, such as IL2 that helps to reduce clinical symptoms in an animal model for multiple sclerosis after oral administration. It also offers cyclotides, a new class of highly specific low toxicity drugs that can be used for several immune-related diseases and cancers. Cyxone collaborates with other medical universities for the development of cyclotide. The company also conducts preclinical studies and phase I clinical trials. It operates across Austria and Germany. Cyxone is headquartered in Malmo, Sweden. Cyxone AB - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides ......
$250

Polyplus-Transfection SA – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Polyplus-Transfection SA (Polyplus) is a biotechnology company that develops and markets solutions for in vivo and in vitro delivery of nucleic acids in research, bioproduction and therapeutics. The company develops its RNA interference such as STICKY SIRNA and SIRNAPLUS for invivo research. Polyplus also develops transfection reagents which include JetPRIME, JetPEI, PEIpro, INTERFERin, PULSin and ZNA among others. Polyplus also provides reagents for preclinical and clinical trials. The company's products find application in gene expression, RNA interference, protein production, in vivo delivery, virus production, molecular biology and diagnostics and protein delivery. It markets its wide range of transfection reagents through a global distributor network. Polyplus is headquarte......
$250

G1 Therapeutics Inc (GTHX) – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary G1 Therapeutics Inc (G1 Therapeutics), formerly G Zero Therapeutics Inc is a healthcare company that develops novel, and small molecule therapies. The company pipeline products include CDK4/6, trilaciclib G1T28 a drug candidate; G1T38 a potential best compound, and G1T48. It undertakes discovery and development of innovative small molecules for utilization in cancer therapy and biodefense applications. G1 Therapeutics discovers new small molecule-based methods that prevent the hematological side effects of cancer chemotherapy and exposure to ionizing radiation. The company also develops small molecules to target specific proteins associated with cell proliferation and growth. It operates through its laboratory located Research Triangle Park. G1 Therapeutics is headquartered in R......
$250

Humabs BioMed SA – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Humabs BioMed SA (Humabs) is an antibody therapeutics biotechnology company that discovers and develops human monoclonal antibodies. The company's pipeline programs include Flu A virus, ebola virus, HBV, rabies virus, JCV, dengue, and others. It develops cellclone technologies, a proprietary platform that delivers a pipeline of human monoclonal antibodies, and demonstrates the antibodies effectiveness in both in-vivo and in-vitro. Humabs technology platform uses immortalized B cells or cultured plasma cells obtained from the blood or lymphoid organs of the donor. The company's pipeline products are used in the treatment of cancer, inflammatory and infectious diseases. It partners with pharmaceutical companies, government agencies, academic institution, and universities. Humabs i......
$250

Nanolek – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Nanolek specializes in the production of import-substituting and novel pharmaceuticals. The company's product portfolio includes vaccines; drugs for treatment of leukemias, brain cancer, breast cancer, stomach and ovarian cancer, colorectal cancer, HIV infection and other diseases. Nanolek also conducts clinical trials on generic, biosimilar and innovative products. It develops drugs in solid dosage forms, and cytostatic drugs in solid and injectable dosage forms through its production facility. Nanolek also offers contract manufacturing services to various organizations such as Merck, Aspen and Aspen Holdings. The company is a joint venture between Rusnano Corp and Epidbiomed. Nanolek is headquartered in Moscow, Russia. Nanolek - Pharmaceuticals & Healthcare - Deals and Alli......
$250

PRA Health Sciences Inc (PRAH) – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary PRA Health Sciences Inc (PRA) is a contract research organization(CRO) which provides clinical development services. The company offers services such as phase I-IV study management, and embedded and functional outsourcing services. It offers solutions in bioanalytical laboratories, biometrics, clinical pharmacology, strategic solutions, post-marketing research, clinical diagnostics, and safety and risk management. PRA spans its expertise in the therapeutic areas of biosimilars, oncology, hematology, respiratory, rare diseases, neurology, infectious diseases, cardio-metabolic and immunology. It caters to pharmaceutical and biotechnology industries. The company has presence in the US, Hong Kong, Russia, India, France, Italy, China, Japan, South Africa, Israel and Colombia among ot......
$250

National Taiwan University Hospital – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary National Taiwan University Hospital (NTUH) is a healthcare service provider that offers biomedical, clinical research and patient care services. The hospital's research activities include community-based intervention programs, multicenter controlled clinical trials, program projects, research and development projects, and research training programs. It provides diagnosis and treatment of cancer, hepatitis, and organ transplantation. NTUH develops diagnosis and treatment in the areas of immunology, dermatology, ophthalmology, cardiovascular, infertility, orthopedics and microsurgery. The hospital offers cellular and molecular studies related to normal structure and function. It also promotes international cooperation in order to gain experience and knowledge from the medical deve......
$250